Sodium Iodide I-131
NDC Package 69945-451-06

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Sodium Iodide I-131 is a . Marketed by Mallinckrodt Nuclear Medicine Llc, this product is identified by NDC 69945-451 and is authorized under FDA application NDA016515.

Identification & Billing

NDC Package Code
69945-451-06
Package Description
1 VIAL in 1 CAN / 6 mL in 1 VIAL
Product Code
11-Digit Billing Format
69945045106

Clinical Specifications

Proprietary Name
Sodium Iodide I-131 Therapeutic
Dosage Form
-

Regulatory & Marketing

Labeler Name
Mallinckrodt Nuclear Medicine Llc
FDA Application #
NDA016515
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
10-27-2015
End Marketing Date
07-01-2018
Listing Expiration
07-01-2018
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (69945-451). Click a package code to view its specific billing and regulatory data.

1 VIAL in 1 CAN / 2 mL in 1 VIAL
1 VIAL in 1 CAN / 3 mL in 1 VIAL
1 VIAL in 1 CAN / 4 mL in 1 VIAL

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69945-451-06 identifies a specific commercial package of 1 vial in 1 can / 6 ml in 1 vial of Sodium Iodide I-131 Therapeutic, labeled by Mallinckrodt Nuclear Medicine Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Mallinckrodt Nuclear Medicine Llc on October 27, 2015. The current certification is valid through July 01, 2018.

How is this Mallinckrodt Nuclear Medicine Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69945045106. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
69945-451-06
11-Digit CMS (5-4-2)
69945-0451-06

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.